Zebrafish models of acute leukemias: Current models and future directions.

Zebrafish models of acute leukemias: Current models and future directions.
复制标题

DOI:
10.1002/wdev.400
复制
发表时间:
2021-11
期刊:
Wiley interdisciplinary reviews. Developmental biology
影响因子:
--
通讯作者:
Grainger S
Grainger S
中科院分区:
其他
文献类型:
--
作者:
Molina B;Chavez J;Grainger S

文献摘要

参考文献

被引文献

相似文献

急性髓性白血病(AML)和急性淋巴性白血病(ALL)是一种异质性疾病,包括一系列具有功能表型丧失和获得的基因突变。最终,这两种方法都会导致骨髓、外周血和其他组织中母细胞的克隆过度生长。因此,正常的造血干细胞功能受到严重阻碍。允许早期检测基因改变和了解这些不同分子病理的技术有助于推进我们的治疗方案向个性化靶向治疗。尽管如此,AML和ALL仍然是世界范围内发病率和死亡率的主要原因,部分原因是尚未开发出针对过多遗传异常的分子疗法。这强调了目前需要更好的治疗发展模型系统。本文回顾了目前斑马鱼的AML和ALL模型,并讨论了如何实施新的基因编辑工具来生成更好的急性白血病模型。
Acute myeloid leukemias (AML) and acute lymphoid leukemias (ALL) are heterogenous diseases encompassing a wide array of genetic mutations with both loss and gain of function phenotypes. Ultimately, these both result in the clonal overgrowth of blast cells in the bone marrow, peripheral blood, and other tissues. As a consequence of this, normal hematopoietic stem cell function is severly hampered. Technlogies allowing for the early detection of genetic alterations and understanding of these varied molecular pathologies have helped to advance our treatment regimens towards personalized targeted therapies. In spite of this, both AML and ALL continue to be a major cause of morbidity and mortality worldwide, in part because molecular therapies for the plethora of genetic abnormalities have not been developed. This underscores the current need for better model systems for therapy development. This article reviews the current zebrafish models of AML and ALL and discusses how novel gene editing tools can be implemented to generate better models of acute leukemias.
DOI: 10.1016/j.ccr.2014.01.032
发表时间: 2014-03-17
期刊: Cancer cell
影响因子: 50.3
作者:
Blackburn JS;Liu S;Wilder JL;Dobrinski KP;Lobbardi R;Moore FE;Martinez SA;Chen EY;Lee C;Langenau DM
通讯作者: Langenau DM
DOI: 10.1177/104345429000700406
发表时间: 1990-10-01
期刊: Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses
影响因子: --
作者:
Betcher, D L;Burnham, N
通讯作者: Burnham, N
DOI: 10.1371/journal.pone.0150188
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者:
Armstrong GA;Liao M;You Z;Lissouba A;Chen BE;Drapeau P
通讯作者: Drapeau P
DOI: 10.3389/fcell.2018.00115
发表时间: 2018
影响因子: 5.5
作者:
Baeten JT;de Jong JLO
通讯作者: de Jong JLO
DOI: 10.1038/leu.2013.132
发表时间: 2013-11-01
期刊: LEUKEMIA
影响因子: 11.4
作者:
Alghisi, E.;Distel, M.;Mione, M. C.
通讯作者: Mione, M. C.